Ureter and Renal Pelvis Cancer

Ureter and renal pelvis cancer refers to the cancer that develops in the ureters (the tubes that carry urine from the kidneys to the bladder) and the renal pelvis (the part of the kidney where urine collects before being passed to the ureter). These cancers are classified as part of upper urinary tract cancers, which also include cancers that affect the kidneys and other structures within the urinary system.

While these cancers are relatively rare compared to other types of urinary tract cancers, they are important to understand due to their potential impact on kidney function and overall health. Most ureter and renal pelvis cancers are transitional cell carcinomas (TCC), which arise from the cells lining the urinary tract. Other types of cancer, such as squamous cell carcinoma and adenocarcinoma, may also occur but are less common.

The incidence of these cancers has been increasing, in part due to improvements in diagnostic techniques and the growing recognition of risk factors like smoking and exposure to carcinogens. Although bladder cancer is the most common cancer in the urinary tract, ureter and renal pelvis cancers are more challenging to treat due to their location and the complexities of the urinary system.

Ureter and renal pelvis cancers develop when cells in these areas become abnormal and begin to grow uncontrollably. Several risk factors can increase the likelihood of developing these cancers, and while the exact cause is not always clear, the following factors are known to contribute:

The most significant and well-established risk factor for developing ureter and renal pelvis cancer is smoking. The chemicals in tobacco smoke are absorbed into the bloodstream and filtered by the kidneys, where they can cause cellular mutations and promote cancer development in the urinary tract. Smoking is responsible for a large percentage of upper urinary tract cancers, and the risk increases with the amount and duration of tobacco use.

People who have chronic kidney disease, particularly those undergoing long-term dialysis, are at an increased risk of developing ureter and renal pelvis cancer. This is because dialysis treatments introduce chemicals into the bloodstream, and the frequent exposure to toxins over time may lead to changes in the cells lining the urinary tract, resulting in cancer.

Exposure to certain chemicals in the workplace has been linked to increased cancer risk in the urinary tract. Carcinogens such as aromatic amines found in industries like textile production, rubber manufacturing, and petroleum refining can increase the risk of ureter and renal pelvis cancer. Workers in these industries may be exposed to these harmful chemicals through inhalation or skin contact.

Certain medications, especially those used in chemotherapy (like cyclophosphamide), are known to increase the risk of developing cancers in the urinary tract, including ureter and renal pelvis cancer. This is due to the toxic effects of these drugs on the cells of the urinary system.